Tyra Biosciences, Inc. (TYRA)
Tyra Biosciences Market Cap : 1.976B for April 9, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Spyre Therapeutics, Inc. | 4.066B |
| Entrada Therapeutics, Inc. | 537.89M |
| BioMarin Pharmaceutical, Inc. | 10.83B |
| Ionis Pharmaceuticals, Inc. | 12.63B |
| Agios Pharmaceuticals, Inc. | 1.929B |
Market Cap Related Metrics
| PEG Ratio | -0.5389 |
| Price to Book Value | 7.537 |
| Price | 36.69 |
| Earnings Yield | -5.55% |
| PEGY Ratio | -0.5389 |